Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

FDA to Review New Fetal Monitoring System

Facebook Twitter LinkedIn Email Comments
ST. LOUIS, Jan. 14 -- Mallinckrodt Inc. reported that its pre-market approval (PMA) application for a new infrared-based fetal oxygen saturation monitoring system called OxiSure has been accepted for filing by the US Food and Drug Administration. An advisory panel will review the application later this month and make a recommendation to the FDA as to whether the application should be approved.
Mallinckrodt's Oxisure system was designed to allow obstetricians to measure directly the arterial oxygenation of a fetus during labor and delivery. Using technology derived from the company's pulse oximeters, the system consists of a non-invasive fetal sensor containing red and IR light sources connected to a monitor that displays the percentage of oxygen in the fetal blood in real time.
Jan 2000
ConsumerNews & FeaturesSensors & Detectors

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.